Shawn Singh - 31 Dec 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
31 Dec 2021
Net transactions value
+$6,005
Form type
4
Filing time
03 Jan 2022, 15:17:51 UTC
Previous filing
02 Jul 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $6,005 +3,623 +8% $1.66 48,998 31 Dec 2021 Direct F1
holding VTGN Common Stock 26,234 31 Dec 2021 By The 1997 Singh Family Trust U/R/D 05/29/97
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)